Therefore, IL-15 can be used in combination with other immunotherapeutic agents for sepsis treatment, such as antibodies that block PD-1 or CTLA-4, which have been found to diminish IL-10 production and PD-1 expression on CD8+ T cell [113]. This evidence concerns the gene IL10 and Sepsis.